ESPE Abstracts (2015) 84 P-3-1144

Central Precocious Puberty in Cerebral Palsy

Patrizia Bruzzia, Maria Francesca Messinab, Alessandra Bartolia, Laura Lucaccionia, Barbara Predieria, Filippo De Lucab & Lorenzo Iughettia

aPaediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; bDepartment of Paediatrics, University of Messina, Messina, Italy

Background: Children affected by cerebral palsy (CP) could experience central precocious puberty (CPP) 20 times more than general population. Nevertheless, the treatment is challenging.

Objective and hypotheses: To compare CPP features and the effects of gonadotropin-releasing hormone agonist therapy (GnRHa) in children with CP and in controls.

Method: The study involved 16 children with CPP and CP (median age (range) at diagnosis of CPP: 7.2 years (2.7–8.9); two males) (group A) and 11 children with CPP but no CP (7.4 years (5.2–7.9); no males) (group B). Auxological, biochemical and instrumental data were collected at diagnosis of CPP and at two follow-up visits.

Results: At diagnosis of CPP, height-SDS-adjusted-for-target-height (H-TH) was lower in A than B (−0.15±1.78 vs 1.56±1.38, P 0.03), while BMI-SDS (0.24±1.15 vs 0.45±0.82, P 0.30) and the discrepancy between chronological and bone ages (1.25±1.01 vs 1.74±1.57 years, P 0.50) did not differ between groups. Basal LH (3.15±2.44 vs. 0.49±0.50 mUI/ml, P 0.009), estradiol levels (29.51±19.12 vs 12.65±6.94 pg/ml, P 0.001) and median ovarian volume (3.37±1.04 vs 1.92±0.75 ml, P 0.006) were significantly higher in A than in B. GnRHa was effective in both groups decreasing gonadotropins, estradiol and signs of pubertal progression. However, it affected differently growth: at second follow-up visit, H-TH (−1.43±1.43 vs 1.48±1.42, P 0.003) and Δ H-SDS (−1.20±1.31 vs 0.21±0.33, P 0.017) were lower in A than B.

Conclusion: CPP in CP seems to progress rapidly supporting the hypothesis of a more intense activation of hypothalamic–pituitary–gonadal axis. We demonstrated that growth failure could partially mislead the diagnosis of CPP in CP and seemed to worsen during follow-up despite GnRHa. The complex management of these patients should be considered when a decision to treat has to be performed. Parents should be adequately supported in order to ensure the best therapeutic choice for each case.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts